Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
MASS | US
0.27
3.99%
Healthcare
Medical Devices
30/06/2024
08/04/2026
7.03
7.21
7.27
6.91
908 Devices Inc. a commercial-stage technology company provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research bioprocessing industrial biotech forensics and adjacent markets. The company's products include MX908 a handheld battery-powered and Mass Spec device that is designed for rapid analysis of gas liquid and solid materials of unknown identity; Rebel a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; Maven and Trace C2 an online device for bioprocess monitoring and control; and ZipChip solution a plug-and-play high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas Europe the Middle East Africa and the Asia Pacific. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston Massachusetts.
View LessStrength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
63.6%1 month
49.3%3 months
62.7%6 months
64.5%-
-
0.78
0.04
0.03
-3.15
0.96
-
-42.30M
243.64M
243.64M
-
-96.53
-
16.10
-22.96
7.45
6.21
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.57
Range1M
1.57
Range3M
2.60
Rel. volume
1.50
Price X volume
2.79M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Cellpoint Inc | CLPT | Medical Devices | 9.17 | 253.05M | 1.10% | n/a | 42.94% |
| Harvard Bioscience Inc | HBIO | Medical Instruments & Supplies | 5.55 | 242.04M | 2.78% | n/a | 61.64% |
| OraSure Technologies Inc | OSUR | Medical Instruments & Supplies | 3.08 | 229.67M | 0.65% | 11.53 | 2.96% |
| Utah Medical Products Inc | UTMD | Medical Instruments & Supplies | 64.53 | 224.38M | 1.67% | 15.31 | 0.22% |
| BRAINSWAY LTD | BWAY | Medical Devices | 13.23 | 220.65M | 7.91% | 503.00 | 10.16% |
| Outset Medical Inc | OM | Medical Devices | 4.2 | 218.78M | 2.44% | n/a | 294.91% |
| Electromed Inc | ELMD | Medical Devices | 24.4 | 205.08M | 2.61% | 39.79 | 0.20% |
| InfuSystem Holdings Inc | INFU | Medical Instruments & Supplies | 9.47 | 201.86M | 1.18% | 702.00 | 73.21% |
| KRMD | KRMD | Medical Instruments & Supplies | 4.19 | 192.13M | -1.18% | n/a | 21.21% |
| enVVeno Medical Corporation | NVNO | Medical Devices | 10.95 | 192.02M | 6.00% | n/a | 3.21% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Comstock Holding Companies Inc | CHCI | Real Estate Services | 18.86 | 185.99M | 0.05% | 14.10 | 17.12% |
| CPI Card Group Inc | PMTS | Building Products & Equipment | 16.56 | 184.77M | 1.41% | 15.61 | -621.78% |
| RE/MAX Holdings Inc | RMAX | Real Estate Services | 5.81 | 182.53M | 1.22% | n/a | 114.28% |
| Douglas Elliman Inc. | DOUG | Real Estate Services | 1.69 | 155.20M | 5.63% | n/a | 62.82% |
| STHO | STHO | Real Estate Services | 8.09 | 107.76M | 1.38% | n/a | 59.21% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 34.71 | 99.68M | 5.16 | 19.82% | |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 5.68 | 92.52M | -5.33% | 9.09 | 39.79% |
| The InterGroup Corporation | INTG | Real Estate Services | 34.9 | 76.05M | -2.10% | n/a | -238.17% |
| Saga Communications Inc | SGA | Broadcasting - Radio | 11.8 | 73.89M | 1.72% | 14.48 | 7.10% |
| ILAG | ILAG | Building Products & Equipment | 3.4 | 61.40M | -6.85% | n/a | 5.48% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -3.15 | 46.09 | Cheaper |
| Ent. to Revenue | 0.96 | 14.34 | Cheaper |
| PE Ratio | - | 30.41 | - |
| Price to Book | 0.78 | 6.21 | Cheaper |
| Dividend Yield | - | 1.78 | - |
| Std. Deviation (3M) | 62.68 | 64.12 | Par |
| Debt to Equity | 0.04 | -145.53 | Expensive |
| Debt to Assets | 0.03 | 0.35 | Cheaper |
| Market Cap | 243.64M | 9.70B | Emerging |